| 9th May 2023 4:36 pm |
RNS |
Form 8.3 - Advanced Oncotherapy plc |
| 5th May 2023 8:56 am |
RNS |
FORM 8.3 - Advanced Oncotherapy |
| 5th May 2023 7:00 am |
RNS |
Additional funding from Secured Convertible Note |
| 4th May 2023 5:01 pm |
RNS |
Form 8.3 - Advanced Oncotherapy Plc |
| 4th May 2023 3:55 pm |
RNS |
Change of Registered Office |
| 3rd May 2023 6:19 pm |
RNS |
Rule 2.9 Announcement |
| 3rd May 2023 4:28 pm |
RNS |
Form 8.3 - Advanced Oncotherapy PLC |
| 2nd May 2023 6:19 pm |
RNS |
Form 8 (OPD) Advanced Oncotherapy plc |
| 18th Apr 2023 7:00 am |
RNS |
Strategic review and formal sale process |
| 31st Mar 2023 6:05 pm |
RNS |
Holding(s) in Company |
| 20th Mar 2023 12:36 pm |
RNS |
Update on Secured Convertible Note Facility |
| 1st Mar 2023 2:54 pm |
RNS |
Secured Convertible Note Facility & other matters |
| 1st Mar 2023 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 1st Mar 2023 2:00 pm |
RNS |
Price Monitoring Extension |
| 27th Jan 2023 4:53 pm |
EQS |
Hardman & Co Research: Q&A on Advanced Oncotherapy (AVO): Current EV significantly below cumulative investment to date |
| 18th Jan 2023 2:00 pm |
RNS |
Operational update |
| 17th Jan 2023 3:10 pm |
EQS |
Hardman & Co Research on Advanced Oncotherapy (AVO): Understanding the significance of 230MeV |
| 30th Dec 2022 1:00 pm |
RNS |
Total Voting Rights |
| 30th Dec 2022 9:24 am |
RNS |
Director/PDMR Shareholding |
| 29th Dec 2022 3:12 pm |
RNS |
Director/PDMR Shareholding |
| 28th Dec 2022 7:00 am |
RNS |
Director/PDMR Shareholding |
| 23rd Dec 2022 12:40 pm |
RNS |
Second Price Monitoring Extn |
| 23rd Dec 2022 12:35 pm |
RNS |
Price Monitoring Extension |
| 12th Dec 2022 7:00 am |
RNS |
Equity Subscription and Issue of Warrants |
| 1st Dec 2022 7:00 am |
RNS |
Issue of Equity |
| 28th Nov 2022 7:00 am |
RNS |
Study showcases the potential superiority of LIGHT |
| 3rd Nov 2022 3:20 pm |
RNS |
Investor / Analyst Event Update |
| 31st Oct 2022 5:00 pm |
RNS |
Total Voting Rights |
| 27th Oct 2022 7:31 am |
RNS |
Presentation highlights superiority of LIGHT |
| 21st Oct 2022 7:00 am |
RNS |
Notice of Investor / Analyst Event |
| 18th Oct 2022 7:00 am |
RNS |
Equity Subscription and Issue of Warrants |
| 30th Sep 2022 5:00 pm |
RNS |
Total Voting Rights |
| 30th Sep 2022 7:00 am |
RNS |
Interim Results |
| 29th Sep 2022 7:15 am |
EQS |
Hardman & Co Research on Advanced Oncotherapy: Major milestone achieved |
| 27th Sep 2022 10:30 am |
RNS |
LIGHT accelerator fully operational |
| 31st Aug 2022 5:00 pm |
RNS |
Total Voting Rights |
| 23rd Aug 2022 3:09 pm |
RNS |
Update re admission of Subscription Shares |
| 19th Aug 2022 7:00 am |
RNS |
Equity Subscription and Issue of Warrants |
| 17th Aug 2022 5:30 pm |
RNS |
Holding(s) in Company |
| 3rd Aug 2022 7:00 am |
RNS |
Equity Subscription and Issue of Warrants |
